Scispace (Formerly Typeset)
  1. Home
  2. Topics
  3. Dialysis (biochemistry)
  4. 1999
  1. Home
  2. Topics
  3. Dialysis (biochemistry)
  4. 1999
Showing papers on "Dialysis (biochemistry) published in 1999"
Patent•
Cassette for delivering fluids, especially dialysis fluids

[...]

Rainer Doenig1, Wolfgang Schulz1•
Fresenius Medical Care1
1 Apr 1999
TL;DR: In this paper, the authors present a method of delivering, balancing, metering and heating a medical fluid, where a fluid conveyed through the lines or at least one delivery chamber is also exposed to heating energy at the same time.
Abstract: A cassette for delivering fluids, especially dialysis fluids, with connecting elements for connecting solution bags and lines leading to the patient for to the dialysis machine, with at least one delivery chamber with an inlet and outlet, with lines for carrying the fluids supplied and delivered, with the walls of the lines being designed at least in some sections so that the lines can be closed by applying a compressive force acting on the walls. Heating and delivery of fluids, in particular dialysis fluids, can be performed effectively and simply by providing at least one area in the cassette where the lines are arranged in such a way that the medium in the lines can be heated to a predetermined set point by means of a heating device arranged outside the cassette. A dialysis machine, in particular for carrying out peritoneal dialysis, hemofiltration and plasma filtration, with a recess or device to accommodate a cassette according to the present invention and with a pump unit for operating the delivery chambers of the cassette. A heating device is provided in the dialysis machine, arranged in the area of the recesses or devices to accommodate the cassette. A method of delivering, balancing, metering and heating a medical fluid, where a fluid conveyed through the lines or at least one delivery chamber is also exposed to heating energy at the same time.

178 citations

Patent•
Apparatuses and processes for whole-body hyperthermia

[...]

Stephen R. Ash
22 Jan 1999
TL;DR: In this article, a high-flow hyperthermia circuit coupled to a low-flow dialysis circuit in a manner which reduces tensioning of membranes in the dialyzer is described.
Abstract: Apparatuses for use in whole-body hypothermia include a high-flow hyperthermia circuit coupled to a low-flow dialysis circuit in a manner which reduces tensioning of membranes in the dialyzer (152) of the dialysis circuit. The arrangement thereby allows proper membrane movement to assist in mixing a sorbent suspension (176) circulated on the sorbent side of the dialyzer. Additional dialysis apparatuses include advantageous disposable packs (300) including the dialyzer (152), sorbent heat exchangers (186) arranged to cooperate with heating elements on base units of the apparatuses, and adaptations for very high flow rates useful in the hyperthermic treatment of cancers.

103 citations

Patent•
Method for determining waste products in the dialysis liquid in dialysis treatment

[...]

Falkvall Thore, Lars-Olof Sandberg, Ivo Fridolin, Lars-Göran Lindberg
4 Jun 1999
TL;DR: In this paper, a method and device for determining in dialysis treatment the content of waste products in the outgoing dialysis liquid from the dialyzer is presented, where the concentration of a certain substance or a combination of substances included in the waste products is effected spectrophotometrically directly on the outgoing Dialysis liquid.
Abstract: Method and device for determining in dialysis treatment the content of waste products in the outgoing dialysis liquid from the dialyzer. Measurement of the concentration of a certain substance or a combination of substances included in the waste products is effected spectrophotometrically directly on the outgoing dialysis liquid from the dialyzer. For that purpose there is provided after the dialyzer in or after the dialysing machine a measuring cell for spectrophotometric measurement. The measurement value obtained is multiplied by the flow of dialysis liquid for determining the content of said substance or said combination of substances in the outgoing dialysis liquid from the dialyzer.

82 citations

Patent•
Dialysis system and cleaning and priming method thereof

[...]

Taku Osaka-shi Nikaido, Mistutaka Osaka-shi Ueda
6 Oct 1999
TL;DR: In this article, a closed-type water-removal control apparatus is used for dialysis, which does not need to use a physiological saline in replenishing a solution or cleaning and priming the dialysis system.
Abstract: A dialysis system which does not need to use a physiological saline in replenishing a solution or cleaning and priming the dialysis system, does not need a troublesome setting operation and can easily and accurately set a flow rate of a replenisher solution. The dialysis system includes a closed type water-removal control apparatus 1, a dialyzer 2, a fresh dialysate line 3 as well as a used dialysate line 4, an RO water pressurizing line 5, an RO water pressurizing pump 51 provided in the RO water pressurizing line 5, an artery side blood line 6, a blood pump 61 provided at the artery side blood line 6 and a vein side blood line 7. According to the dialysis system, by pressurizing RO water into a communication line of the used dialysate, dialysate is made to flow from a dialysate flow path 21 into a blood flow path 22 through a dialysis membrane 23 of the dialyzer 2 and the inside of a blood circulation path can be cleaned and primed.

71 citations

Book Chapter•10.1159/000060009•
Pathophysiology of the oxidative stress and its implication in uremia and dialysis.

[...]

Francesco Galli1, F. Canestrari, G. Bellomo•
University of Urbino1
01 Jan 1999-Contributions To Nephrology

69 citations

Patent•
Method of preparing a batch of dialysis solution

[...]

Zbylut J. Twardowski
12 Apr 1999
TL;DR: In this article, a hemodialyzer apparatus consisting of a reusable dialyzer membrane as well as reusable blood flow path and dialysis flow path units is used for daily dialysis at home.
Abstract: A hemodialyzer apparatus comprises a reusable dialyzer membrane as well as reusable blood flow path and dialysis flow path units. The apparatus automatically primes itself and makes dialysis solution from dry chemicals, concentrates, and fresh water which is provided to the apparatus. Also, after use, the apparatus automatically prepares cleaning and rinsing solution for the cleaning and rinsing of the dialyzer membrane as well as the dialyzate and blood flow path means, to provide a system which is so simplified in terms of automatic operation that it may be usable for daily dialysis at home.

62 citations

Patent•
Dialysis graft system with self-sealing access ports

[...]

Renan Uflacker, Andre Uflacker
24 May 1999
TL;DR: In this paper, a dialysis-access graft fistula having self-sealing ports for use in hemodialysis was presented. But this method was not suitable for the use of the fistula in the treatment of kidney failure.
Abstract: This invention provides a dialysis-access graft fistula having self-sealing ports for use in hemodialysis. The self-sealing ports can be repeatedly used for the cannulation required for the blood flows associated with hemodialysis. The ports self-seal after each puncture.

58 citations

Patent•
Buffered compositions for dialysis

[...]

Robin Callan, Walter A. Van Schalkwijk, James J. Cole, Suhail Ahmad
19 Oct 1999
TL;DR: In this article, the buffering agent allows a physiologically acceptable amount of citrate to maintain the desired pH of the dialysate, which is used for acid concentrates.
Abstract: Acid concentrates, and dialysate compositions prepared therefrom, contain citric acid and an effective amount of a buffering agent selected from acetate and/or lactate. The buffering agent allows a physiologically acceptable amount of citrate to maintain the desired pH of the dialysate.

56 citations

Journal Article•10.1016/S0041-1345(99)00722-8•
Economics of dialysis and renal transplantation in the developing world.

[...]

Kirpal S. Chugh1, Vivekanand Jha1, Sumant S. Chugh1•
Post Graduate Institute of Medical Education and Research1
1 Dec 1999

56 citations

Journal Article•
Clinical practice guidelines for initiation of dialysis. Canadian Society of Nephrology.

[...]

David N. Churchill, Peter G. Blake, Kailash Jindal, E. B. Toffelmire, Marc Goldstein 
01 Jun 1999-Journal of The American Society of Nephrology

49 citations

Journal Article•10.1021/JF9812329•
Analysis of patulin in apple juice by diphasic dialysis extraction with in situ acylation and mass spectrometric determination.

[...]

Fuu Sheu1, Yuan T. Shyu1•
National Taiwan University1
08 Jun 1999-Journal of Agricultural and Food Chemistry
TL;DR: A procedure combining diphasic dialysis extraction with in situ acylation and gas chromatography/mass spectrometry (GC/MS) determination was developed for detection and quantification of the mycotoxin patulin in apple juice and showed potential for other applications.
Abstract: A procedure combining diphasic dialysis extraction with in situ acylation and gas chromatography/mass spectrometry (GC/MS) determination was developed for detection and quantification of the mycotoxin patulin in apple juice. Apple juice samples spiked with 4-N,N-dimethylaminopyridine were dialyzed using methane chloride and acetic anhydride inside dialysis tubing. Patulin was derivatized into its acetate and collected in the tubing after diphasic dialysis and was directly determined using GC/MS with the selective ion monitoring mode without further concentration and cleanup steps. Quantification was carried out by a calibration curve with an internal standard of correlation. The appropriate parameters of both dialysis and derivatization were examined. The linear range of the calibration curve was found to be 10−250 μg/L for patulin, and the limit of quantification was 10 μg/L. Levels of patulin ranging from 0 to 107.2 μg/L with 77−109% recovery were found in 10 apple samples. The technique combining dipha...
Journal Article•10.1177/089686089901900309•
Effects of amino acid dialysis compared to dextrose dialysis in children on continuous cycling peritoneal dialysis.

[...]

IU Qamar1, Donna Secker1, L Levin1, JA Balfe1, S Zlotkin1, J W Balfe1 •
University of Toronto1
01 Jan 1999-Peritoneal Dialysis International
TL;DR: Amo acid dialysis is an efficient form of peritoneal dialysis that should be considered for children with poor nutritional status for whom enteral nutrition supplementation has been unsuccessful and further study is needed to determine the optimal amount of amino acids to deliver, the best time to administer the aminoacid dialysis fluid, and the benefits of adding dextrose to the amino acid solution.
Abstract: ObjectiveTo compare the biochemical and nutritional effects of amino acid dialysis with dextrose dialysis in children receiving continuous cycling peritoneal dialysis (CCPD).DesignA prospective ran...
Journal Article•10.1046/J.1523-1755.1999.0550031128.X•
Hypertension/hypotension in dialysis.

[...]

Bernard Charra, Charles Chazot, G.U.Y. Laurent
01 Mar 1999-Kidney International
Patent•
Patient connector for peritoneal dialysis

[...]

Joachim Dr Doepper1, Wolfgang Schulz1•
Fresenius Medical Care1
26 Mar 1999
TL;DR: In this paper, a connector for peritoneal dialysis is described, which includes a base body having a first tube for attachment of a container for dialysis solution, and a second tube for attaching a peritoneAL catheter.
Abstract: A connector for use in peritoneal dialysis, includes a base body having a first tube for attachment of a container for dialysis solution, and a second tube for attachment of a peritoneal catheter. Positioned in a passageway between the first tube and the second tube is a closure piece which so interacts with an actuator that an operation of the actuator causes the closure piece to move in a linear direction from a first position into a second position in which the fluid flow between the first tube and the second tube is closed while the first tube is sealed off.
Patent•
Apparatus for determining hemodialysis parameters

[...]

Frank A. Gotch1, Thomas I. Folden1•
Fresenius Medical Care1
5 Jan 1999
TL;DR: In this article, a dialyzer with a semipermeable membrane delimiting a first chamber through which blood circulates and a second chamber through the circulating dialysis solution is described.
Abstract: Dialysis system comprising: a source (30) of dialysis solution; a dialyzer (38) having a semipermeable membrane delimiting a first chamber through which blood circulates and a second chamber through the circulating dialysis solution, the second chamber being connected such to said source (30) dissolution dialysis through a via (32) input dialysis solution and said second chamber also being connected to a means (42) output dialysis solution, a track (76) of arterial blood and a means (64) venous blood connected to an inlet and outlet of said first chamber of the dialyzer (38) respectively, means (66) for placing said satellite (76) of arterial blood and said channel (64) venous blood in a first orientation, wherein said via blood carries blood from an upstream portion of the fistula of a patient and said venous line carries blood toward a downstream portion of said fistula and for reconfiguration said arterial and venous lines to a second or G uidance, wherein said arterial line carries blood from a downstream portion of said fistula and said venous line carries blood toward an upstream portion of said fistula; means (46, 106) to determine a first value for the concentration of a solute in said channel (42) output dialysis solution for dialysis conditions in which said arterial and venous lines are in said first orientation means (46 , 106) to determine a second value for the concentration of said solute in said channel (42) output dialysis solution for dialysis conditions in which said arterial and venous lines are in said second orientation, and means (200) for calculating from said first and second values, a hemodialysis parameter.
Journal Article•10.1097/00041552-199911000-00002•
Dialysis and transplantation.

[...]

Leendert C. Paul
01 Nov 1999-Current Opinion in Nephrology and Hypertension
Patent•
Diagnostic test container and method of sampling

[...]

Philip Peter Monro
11 Feb 1999
TL;DR: In this article, a container has a single primary chamber linked to a single secondary chamber via a common wall in which has been fused a semi-permeable membrane, and a lid for the primary chamber enables sealing of a sample (not shown) inserted into the secondary chamber, sealingly enclosing any dangerous fraction of the sample, which fraction and the lid closed any infectious material hermetically sealed in as this cannot cross the membrane, due to the latter being provided with a cut-off matched to the molecular size of the type of sample with which the container is to
Abstract: A container has a single primary chamber linked to a single secondary chamber via a common wall in which has been fused a semi-permeable membrane. A lid for the primary chamber enables sealing of a sample (not shown) inserted into the primary chamber, sealingly enclosing any dangerous fraction of the sample, which fraction and the lid closed any infectious material hermetically sealed in as this cannot cross the semi-permeable membrane, due to the latter being provided with a cut-off matched to the molecular size of the type of sample with which the container is to be used. However, material of a lower molecular weight than the dangerous fraction can move across the membrane in either directions by dialysis or osmosis.
Journal Article•10.1177/089686089901900105•
Measurement of continuous ambulatory peritoneal dialysis prescription adherence using a novel approach.

[...]

Mary Ann Sevick1, Douglas W. Levine1, John M. Burkart1, Michael V. Rocco1, Jennifer Keith1, Stuart J. Cohen1 •
Wake Forest University1
01 Jan 1999-Peritoneal Dialysis International
TL;DR: A novel approach to monitoring the adherence of continuous ambulatory peritoneal dialysis patients to their dialysis prescription was tested and it was indicated that some patients concentrated their exchange activities during the day, with shortened dwell times between exchanges.
Abstract: ObjectiveThe purpose of the study was to test a novel approach to monitoring the adherence of continuous ambulatory peritoneal dialysis (CAPD) patients to their dialysis prescription.DesignA descri...
Patent•
Device for measuring access flow by dialysis

[...]

Jan Sternby, Gary Joel Mishkin, Assbrink Perry, Eddie Nilsson
22 Oct 1999
TL;DR: In this paper, an arterial needle removes blood from the access to an extracorporeal circuit comprising a dialyzer and a venous needle returning the blood to the access site.
Abstract: An arterial needle removes blood from the access to an extracorporeal circuit comprising a dialyzer and a venous needle returns the blood to the access site. Blood passes along one side of the membrane of the dialyzer and dialysis fluid along the other side. Fistula or access recirculation is detected by changing the blood flow rate, monitoring the concentration of a substance in the dialysate emitted from the dialyzer and correlating a change in the concentration to the change of the blood flow rate.
Patent•
Appararus for providing a dialysis liquid which comprises a device for monitoring of selected parameters of said liquid and method for monitoring of selected parameters of the dialysis liquid during a dialysis treatment

[...]

Christmann-Braun Horst, Franz-Wilhelm Koerdt, Klaus Metzner
5 Mar 1999
TL;DR: In this article, a selected parameter of a dialysis liquid is monitored by determining the propagation velocity of ultrasonic pulses transmitted through the liquid, and the selected parameter is determined by a system that receives the dialysis fluid, transmits the ultrasonic pulse through the fluid, receives the ultrasonic pulses and determines the velocity of the pulse propagation in the liquid.
Abstract: A selected parameter of a dialysis liquid is monitored by determining the propagation velocity of ultrasonic pulses transmitted through the liquid An Independent claim is also included for dialysis liquid preparation equipment including a dialysis liquid parameter monitoring system which receives (28) the dialysis liquid, transmits (29, 30) ultrasonic pulses through the liquid, receives (29, 30) the ultrasonic pulses and determines (35) the ultrasonic pulse propagation velocity through the liquid and thus the selected parameter
Patent•
Method and device for monitoring a blood vessel access

[...]

Wolfgang Kleinekofort1•
Fresenius Medical Care1
16 Oct 1999
TL;DR: For monitoring a vascular access during a dialysis treatment, the pressure in both the arterial and the venous branch (5, 7) of the extracorporeal blood circuit by means of pressure sensors (18, 19) is monitored as discussed by the authors.
Abstract: For monitoring a vascular access during a dialysis treatment, the pressure in both the arterial and the venous branch (5, 7) of the extracorporeal blood circuit by means of pressure sensors (18, 19) is monitored. Characteristic values (W
Patent•
Process for removing toxins from blood using zirconium metallate or titanium metallate compositions

[...]

John D. Sherman1, David S. Bem1, Gregory J. Lewis1•
UOP LLC1
29 Mar 1999
TL;DR: In this paper, a process for removing toxins from blood is disclosed, which involves contacting the blood with a microporous ion exchanger to remove toxins in the blood, and then the blood can be contacted with a dialysis solution which is then contacted with the ion exchange.
Abstract: A process for removing toxins from blood is disclosed. The process involves contacting the blood with a microporous ion exchanger to remove toxins in the blood. Alternatively, the blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The microporous ion exchangers are represented by the following empirical formulae: A.sub.p M.sub.x Zr.sub.1-x Si.sub.n Ge.sub.y O.sub.m (I) and A.sub.p M.sub.x Ti.sub.1-x Si.sub.n Ge.sub.y O.sub.m (II)
Journal Article•10.1016/S0021-9673(99)00180-6•
Preconcentration of quinolones by dialysis on-line coupled to high-performance liquid chromatography

[...]

Tatjana Zupančič1, Boris Pihlar1•
University of Ljubljana1
23 Apr 1999-Journal of Chromatography A
TL;DR: Optimisation of the experimental conditions for selective dialytic enrichment are described and effects of interfering substances present in real samples on the variation of dialysis efficiency can be minimised by successive dialysis runs of the original and spiked samples.
Journal Article•
Daily dialysis and long-term outcomes--the Lynchburg Nephrology NHHD experience.

[...]

Lockridge Rs
01 Dec 1999-Nephrology news & issues
Journal Article•10.1016/S0272-6386(99)70094-6•
Timely initiation of dialysis

[...]

Paul F. Williams1•
Suffolk University1
01 Sep 1999-American Journal of Kidney Diseases
Patent•
Method for controlling a dialysis apparatus with a means for preparation of dialysate and device for this

[...]

Carsten Müller
18 Jan 1999
Journal Article•10.1016/S0272-6386(99)70408-7•
What is our duty to a "hateful" patient? Differing approaches to a disruptive dialysis patient.

[...]

David Z. Levine1•
Boston Medical Center1
01 Oct 1999-American Journal of Kidney Diseases
Journal Article•10.1007/PL00009057•
Improving an on-line feeding strategy for fed-batch cultures of hybridoma cells by dialysis and 'Nutrient-Split'-feeding

[...]

J. O. Schwabe1, Ralf Pörtner1, Herbert Märkl1•
University of Hamburg1
02 Jun 1999-Bioprocess Engineering
TL;DR: The feeding strategy was to minimise the formation of inhibiting metabolites and to increase the yield of monoclonal antibodies in fed-batch cultures of hybridoma cells by a balanced supply of substrates by using a process control system based on fieldbus technology.
Abstract: The concept of the feeding strategy was to minimise the formation of inhibiting metabolites and to increase the yield of monoclonal antibodies in fed-batch cultures of hybridoma cells by a balanced supply of substrates. A process control system based on fieldbus technology was used for monitoring and control. External program routines were implemented to control dissolved oxygen (DO) and to calculate the oxygen uptake rate (OUR) and cumulative oxygen consumption (COC) simultaneously. A concentrated feed solution was supplied according to the off-line estimated stoichiometric ratio between oxygen and glucose consumption (GC). Feeding was initiated automatically when the OUR decreased due to substrate limitation. The antibody concentration increased three-fold compared to the conventional batch culture by applying this strategy. But it was not possible to avoid inhibition by ammonia during the fed-batch phase. This was accomplished by the use of a dialysis membrane. Dialysis fed-batch cultures were performed in a membrane dialysis reactor with a `nutrient-split' feeding strategy, where concentrated medium is fed to the cells and toxic metabolites are removed into a buffer solution. This resulted in a ten-fold increase of the antibody concentration compared to the batch. Amino acid concentrations were analysed to identify limiting conditions during the cultivation and to analyse the performance of the nutrient supply in the fed-batch and dialysis fed-batch.
Book•10.1159/ISBN.978-3-318-00454-0•
Vitamin E-bonded membrane : a further step in dialysis optimization

[...]

C. Ronco, G. La Greca
27 Oct 1999
TL;DR: Study of mechanisms involved in mononuclear cell activation increased red blood cell survival reduces the need of erythropoietin in haemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane.
Abstract: Pathophysiology of the oxidative stress and its implication in uremia and dialysis vitamin E as an antioxidant agent chronic haemolysis and erythrocyte survival in haemodialysis patients treated with vitamin E-modified dialysis filters development of vitamin E-modified membrane evaluation of excebrane by infrared imaging hydraulic and flow dynamic characteristics of vitamin E-bonded dialyzers urea clearance and ionic dialysance of excebrane haemodialyzers effect of several cellulosic dialytic membranes on hyperhomocysteinemia and on the oxidative stress in dialysis patients - any role for curay and vitamin E? hollow-fiber dialyzer employing vitamin E-bonded membrane - a morphological analysis does vitamin E bound on dialysis membrane improve the LDL susceptibility to oxidation? lessons from an in vitro model effect of vitamin E conjugated to dialysis membranes on immunohaematopoietic cell growth and signalling effects of vitamin E-modified dialyzer (Excebrane) on beta-2-microglobulin structure and removal lipid peroxidation, leukocyte function and apoptosis in haemodialysis patients treated with vitamin E-modified filters morphologic evaluation of red blood cells using vitamin E-modified dialysis filters Excebrane - haemocompatibility studies by the intradialytic monitoring of oxygen saturation effect of a new vitamin E-coated membrane on glycoxidation during haemodialysis in vivo evaluation of biocompatibility of a new dialyzer employing the vitamin E-modified cellulose membrane "Excebrane E" - study of mechanisms involved in mononuclear cell activation increased red blood cell survival reduces the need of erythropoietin in haemodialyzed patients treated with exogenous glutathione and vitamin E-modified membrane a chemiluminescence assay for the detection of reactive oxygen species produced by human neutrophils - in vitro comparison of vitamin E-modified multilayer haemodialysis filter with a polysulfone dialyzer immunological biocompatibility characterization of a vitamin E-bonded membrane long-term effects of vitamin E-bonded dialysis membrane on mononuclear cell activation, malondialdehyde generation and endothelial function in ESRD patients effect of vitamin E-modified regenerative cellulose membrane on neutrophil superoxide anion radical production and lipid peroxidation suppressive effects of vitamin E-coated dialysis membrane on haemodialysis-induced neutrophil activation.
Patent•
Apparatus for dialysis treatment

[...]

Horst Christmann-Braun1, Matthias Dr. Krämer1, De Ven Andreas Dr. Van1•
Fresenius Medical Care1
18 Nov 1999
TL;DR: In this paper, an extracorporeal blood circuit is connected in a device for dialysis treatment, in which the blood chamber (3) a through a semipermeable membrane (2) into the blood chambers and a dialysis (4) divided dialyzer (1), is used to set a reduced dialysing fluid flow through the dialyzing fluid part of the dialysis fluid diverted via a bypass line.
Abstract: Bei einer Vorrichtung zur Dialysebehandlung mit einem extrakorporalen Blutkreislauf, in den die Blutkammer (3) einer durch eine semipermeable Membran (2) in die Blutkammer und eine Dialysierflussigkeitskammer (4) unterteilten Dialysators (1) geschaltet ist, wird zur Einstellung eines verringerten Dialysierflussigkeitsflusses durch die Dialysierflussigkeitskammer ein Teil der Dialysierflussigkeit uber eine Bypassleitung (14) umgeleitet. Is connected in a device for dialysis treatment with an extracorporeal blood circuit, in which the blood chamber (3) a through a semipermeable membrane (2) into the blood chamber and a dialysis (4) divided dialyzer (1), is used to set a reduced dialysing fluid flow through the dialyzing fluid part of the dialysis fluid diverted via a bypass line (14). Da bei verringertem Dialysierflussigkeitsflus die Konzentration einer Substanz im Dialysierflussigkeitsweg im wesentlichen die Konzentration der selben im Blutkreislauf annimmt, konnen hamodynamische Parameter allein aus Messungen auf der Dialysierflussigkeitsseite bestimmt werden. Since at reduced dialysis solution, the concentration of a substance in the dialysis fluid takes the concentration of the same in the bloodstream essentially hemodynamic parameters can be determined solely from measurements on the dialysate side. Wenn die Dialysierflussigkeit uber die Bypassleitung umgeleitet wird, ergeben sich keine Probleme bei der Temperaturregelung. When the dialysis fluid is diverted through the bypass line, there are no problems with the temperature control result. Auch die Zusammensetzung und die Homogenitat der Dialysierflussigkeit entspricht genau den Verhaltnissen wahrend der Dialysebehandlung. Also the composition and the homogeneity of the dialysis fluid corresponding exactly to the ratios during the dialysis treatment.
...

Tools

SciSpace AgentBiomedical AgentSciSpace RecruitSciSpace for EnterpriseAgent GalleryChat with PDFLiterature ReviewAI WriterFind TopicsParaphraserCitation GeneratorExtract DataAI DetectorCitation Booster

Learn

ResourcesLive Workshops

SciSpace

CareersSupportBrowse PapersPricingSciSpace Affiliate ProgramCancellation & Refund PolicyTermsPrivacyData Sources

Directories

PapersTopicsJournalsAuthorsConferencesInstitutionsCitation StylesWriting templates

Extension & Apps

SciSpace Chrome ExtensionSciSpace Mobile App

Contact

support@scispace.com
SciSpace

© 2026 | PubGenius Inc. | Suite # 217 691 S Milpitas Blvd Milpitas CA 95035, USA

soc2
Secured by Delve